Eli Lilly Corp. buy Barclays PLC
Start price
21.02.26
/
50%
€849.00
Target price
21.02.27
€1,145.6
Performance (%)
-7.62%
Price
14:45
€784.30
Summary
This prediction is currently active. With a performance of -7.62%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 21.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -2.541% | -2.541% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by Barclays_PLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $1,350.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Barclays_PLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€771.40
31.10.24
31.10.24
€896.61
31.10.25
31.10.25
-3.29%
01.11.25
01.11.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€859.00
11.07.24
11.07.24
€941.16
11.07.25
11.07.25
-21.42%
12.07.25
12.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€676.00
07.02.24
07.02.24
€751.76
07.02.25
07.02.25
26.20%
08.02.25
08.02.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€580.50
23.01.24
23.01.24
€625.12
23.01.25
23.01.25
25.75%
24.01.25
24.01.25